Completed Project
|
|
| Project No. |
PI |
Project Title |
| K1001 |
John F. Tisdale |
Development of a small-size b-globin vector for efficient vector production and gene marking |
| K1002 |
Masato Yamamoto |
Development of a CD133-targeted adenoviral vector system |
| K1007 |
Jianda HU |
Development of novel investigational HLA-A24 restrictive cancer vaccine for multiple myeloma |
| K2001 |
Jacob Corn |
Development of a novel off-target detection tool for CRISPR-Cas3 |
| K2002 |
Konrad Hochedlinger |
Modulating epigenetic regulation to promote muscle regeneration and rejuvenation |
| K2003 |
Hyeseong Cho |
Elucidation of mechanisms underlying eukaryotic DNA repair and transcription |
| K2006 |
Watcharin Loilome |
Multi-omic analysis toward an understanding of therapeutic response for a precision medicine in cholangiocarcinoma |
| K2007 |
Miguel Esteban |
Dissecting the molecular roadmap of in vivo reprogramming |
| K2009 |
Jiangning Song |
Artificial intelligence-enabled cancer diagnosis, type classification and mutation prediction by leveraging deep learning and histopathology image analysis |
| K2102 |
Leyi Wei |
Dual learning based generative adversarial networks for imputation of single-cell RNA-seq data |
| K3002 |
Daniel SAUTER |
Regulation of cellular gene expression by endogenous retroviruses in infectious and non-infectious diseases |
| K3004 |
Eicke Latz |
The impact of DNases on alveolar hemorrhage |
| K3005 |
Omar Abdel-Wahab |
Clonal hematopoiesis and a variety of related disorders in the aged population |
| |
|
|
| |
|
|
Continuing Project
|
|
| Project No. |
PI |
Project Title |
| K22-1039 |
Yan Xiyun |
Ferritin nanocaged doxorubicin for targeted hepatocellular carcinoma therapy |
| K22-1040 |
鄭 允文 |
Reconstruction of human liver in Fah–/–Rag2–/–IL2rg–/– rats with hiPSC derived liver organoids |
| K22-1041 |
DUPREZ Estelle |
Inflammation, hematopoietic aging, and clonal drift: deciphering the role of the transcription factor PLZF |
| K22-1059 |
COQ Jacques-Olivier |
Mesenchymal Stromal Cell Therapy to Prevent Neurodevelopmental Disorders related to Low-Birth-Weight |
| K22-1072 |
Passegue Emmanuelle |
Development of novel therapeutics targeting hematopoietic stem cell (HSC) aging |
| K22-1073 |
Wilkinson Adam |
Hematopoietic stem cell rejuvenation therapies |
| K22-2043 |
Patrick Tan |
Understanding of epigenetic heterogeneity in intractable cancers |
| K22-2056 |
何 暁東 |
Functional polarization of tumour-associated macrophages by tumor microenvironment |
| K22-2057 |
Leonhardt Heinrich |
Regulation and Function of DNA methylation |
| K22-2103 |
Yeh Iwei |
The development of acral melanoma model and a novel early diagnostic method based on stem cell dynamics |
| K22-3045 |
Ernst Peter |
Development of mucosal vaccines designed for infant based on the understanding of the infantile nasopharyngeal and gut mucosal immune system |
| K22-3046 |
Leonard Warren |
Control of T cell and NK cell exhaustion to overcome viral infection and cancer development |
| K22-3058 |
Ginhoux Florent |
Investigating Putative Dendritic Cell Precursors (pre-DC) with Neutrophil Progenitor Properties |
| K22-3062 |
Tsai Catherine |
Harnessing the group A streptococcus pilus to develop novel universal influenza vaccines |
| K22-3063 |
Katsikis Peter |
Human Systems Immunology of vaccine and immunotherapy |
| K22-3068 |
Hirasawa Kensuke |
Programmed cell death induced by human coronavirus infection |
| K22-3069 |
Qin Zhihai |
To study the molecular mechanism of COVID-19 protein ORF3a to stimulate the production of cytokine in macrophages |
| K22-3076 |
Simon Anna |
Elucidation of mechanisms involved in tissue specific immunity during infection and vaccination |
| K22-3082 |
Mi Kaixia |
Analysis of the mechanisms of co-infection with Mycobacterium and HIV in human macrophage linage cells |
